HB3367

Oklahoma HB3367 mandates electronic prescriptions for certain controlled substances and outlines related requirements.

Oklahoma HB3367 requires electronic prescriptions for compounded prescriptions, compounded infusion prescriptions, and prescriptions issued under approved research protocols. It mandates electronic prescribing for Schedules II, III, IV, and V substances, with exceptions for certain circumstances. The bill allows electronic prescriptions with electronic signatures to serve as original prescriptions. It also outlines procedures for the retention and use of official prescription forms, including requirements for registered practitioners. The act becomes effective November 1, 2026.